Johns Hopkins Psychiatry Guide
Chlorpromazine
INDICATIONS
FDA
FDA
- Bipolar disorder (manic episode)
- Schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 6, 2025
Citation
Qureshi, Imran. "Chlorpromazine." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787502/all/Chlorpromazine.
Qureshi I. Chlorpromazine. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787502/all/Chlorpromazine. Accessed October 8, 2025.
Qureshi, I. (2025). Chlorpromazine. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787502/all/Chlorpromazine
Qureshi I. Chlorpromazine [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787502/all/Chlorpromazine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chlorpromazine
ID - 787502
A1 - Qureshi,Imran,PharmD, BCPP
Y1 - 2025/09/06/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787502/all/Chlorpromazine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
